Diabetes UK 2024 Resource Hub  – 

Welcome to our resource hub for Diabetes UK Professional Conference 2024! This is a one-stop-shop for all your DUK 2024 needs. We will be updating the resource hub daily, so check back in for the latest on this fantastic meeting.

  1. Conference Website
  2. Conference Registration
  3. Day-by-Day Conference Preview
  4. Conference Program

Day-of Conference Reports

  1. Diabetes UK 2024 Day #1 Highlights
  2. Diabetes UK 2024 Day #2 Highlights
  3. Diabetes UK 2024 Day #3 Highlights

Diabetes Therapy Highlights

  1. England audit highlights concerning underuse of urine albumin-creatinine ratio testing for early diagnosis of diabetic kidney disease
  2. Pharmacotherapy for kidney disease: Prof. Kamlesh Khunti discusses efficacy of SGLT-2 inhibitors and GLP-1 receptor agonists across broad patient population
  3. Prof. Tim Barrett discusses T1D Plus trials platform investigating verapamil in combination with Tzield and other immunotherapies
  4. “Type 1 diabetes is not a single disease”: Prof. Noel Morgan presents new data supporting the existence of endotypes
  5. Quick Take: Updates on current and emerging diabetes and obesity therapies from a UK lens
  6. Targeting unifying drivers of MASLD: Oxford’s Dr. Thomas Marjot encourages HCPs to focus on encouraging weight and glycemic control
  7. The endothelial glycocalyx may be the missing link between albuminuria and systemic vascular disease in microvascular complications of diabetes
  8. Professor Angus Jones explains that diagnosis of type 1 diabetes in adults is like a “needle in a haystack” in RD Lawrence Lecture
  9. Professor Naveed Sattar discusses the interplay of cardio-renal-metabolic disease in type 1 diabetes and type 2 diabetes

Diabetes Technology Highlights

  1. Prof. Roman Hovorka delivers exceptional Banting Memorial Lecture on AID
  2. Small study on AID in pregnancy in T1D (n=36) finds +8.2 hour/day increase in pregnancy TIR and 1.7% reduction in A1c across four commercial systems
  3. Poster hall highlights early UK Omnipod 5 data demonstrating impressive TIR increases and low hypo
  4. “The system puts all the pieces together”: Ms. Amy Jolley highlights Medtronic’s Smart MDI system, discussing candidates, funding, and new features
  5. Ms. Kathryn Fraser does a deep dive into the Control-IQ algorithm
  6. University of Nottingham’s Dr. Pooja Sachdev and Ms. Ressy Cresswell review ins and outs of algorithm setting adjustments for children on AID
  7. Trial outcomes from T1D pregnancies (n=2,055) following CGM rollout: Prof. Helen Murphy shares insightful results
  8. Prof. Alice Cheng on the future of insulin, technology, and digital health

Diabetes Big Picture Highlights

  1. Shaping the future of diabetes care: Prof. Melanie Davies on innovation, people, interventions, and partnerships
  2. Genetic variant in South Asian people may lead to underestimation of A1c levels and delayed diabetes diagnosis, genome-wide association study finds
  3. University of Edinburgh’s Prof. Sarah Wild on the changing patterns of diabetes in the 21st century
  4. Workshop spotlights cardio-renal-metabolic disease, with a focus on primary care and community-based solutions
  5. National UK consensus on management of T2D in children and young people
  6. Harry Keen Rank Nutrition Lecture: Dr. John Wilding on weight loss as primary goal in T2D treatment and prevention
  7. Professor Roy Taylor discusses how the new understanding of T2D informs roll out of remission services
  8. Quick Take: Screening for diabetic retinopathy is evolving as barriers remain
  9. Quick Take: National Diabetes Audit as a source for quality indicators that can influence coverage for tech and therapies
  10. Quick Take: In the exhibit hall, we saw Abbott, AstraZeneca, Dexcom, Lilly, Novo Nordisk, and more
  11. Papers to People: Profs. Partha Kar and Helen Murphy on implementing policy change with PWDs
  12. Prof. Kath Barnard Kelly, Dr. Vicky McKechnie, Prof. Pratik Choudhary and Dr. Nicole de Zoysa on the biopsychosocial impact of tech and hyperglycemia aversion

Exhibit Hall

Therapy

  1. AstraZeneca
  2. Lilly
  3. Lilly/BI
  4. Madrigal
  5. Menarini Farmaceutica
  6. Sanofi

Technology

  1. Abbott
  2. Dexcom
  3. embecta
  4. Glooko
  5. Insulet
  6. Medtronic
  7. Medtrum
  8. Ypsomed

Big Picture

  1. JDRF UK
  2. Diabetes UK
  3. NHS England

Previous Diabetes UK Coverage on CCKB

  1. Diabetes UK 2023 Resource Hub
  2. Diabetes UK 2022 Resource Hub
  3. Diabetes UK 2021 Full Report
  4. Diabetes UK 2019 Full Report
  5. Diabetes UK 2018 Full Report
  6. Diabetes UK 2017 Full Report
  7. Diabetes UK 2016 Full Report
Diabetes UK 2024 Resource Hub -
Top